From laggards to leaders: Small caps on the rise Vir Biotechnology (NASDAQ:VIR) reported second-quarter 2026 results ...

Battelle recently welcomed members of the National Security Commission on Emerging Biotechnology (NSCEB) to its Columbus ...

Upstream Biotechnology unlocks crops’ own defense systems in response to disease and environmental stress without ...

Vir Biotechnology, Inc. (VIR) came out with quarterly earnings of $0.47 per share, missing the Zacks Consensus Estimate of $0.83 per share. This compares to a loss of $0.8 per share a year ago. These ...

SAN DIEGO, CA, UNITED STATES, August 4, 2026 /EINPresswire.com/ -- Key Takeaways Investigational New Drug (IND) ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

More than 100 speakers will gather in the Saudi capital from 14 to 16 September for the fourth edition of the Summit, with delegations from over 70 countries expected to attend as the Kingdom builds ...

Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...

SC451 for type 1 diabetes drives upside, but valuation & dilution risk loom. Click here to read more about the SANA stock.

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce ...

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

What are the qualifications of the people conducting IDTechEx research? Content produced by IDTechEx is researched and written by our technical analysts, each with a PhD or master's degree in their ...